Prophylactic intra-aortic balloon counterpulsation in high risk cardiac surgery: The PINBALL Pilot multicentre, registry-linked, randomised, controlled feasibility trial

ANZICS Clinical Trials Group

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

BACKGROUND: Prophylactic intra-aortic balloon counterpulsation (IABC) is commonly used in selected patients undergoing coronary artery bypass graft (CABG) surgery, but definitive evidence is lacking. The aim of the multicentre PINBALL Pilot randomised controlled trial (RCT) was to assess the feasibility of performing a definitive trial to address this question.

METHODS: Patients listed for CABG surgery with impaired left ventricular function and at least one additional risk factor for postoperative low cardiac output syndrome were eligible for inclusion if the treating surgical team was uncertain as to the benefit of prophylactic IABC. The primary outcome of feasibility was based on exceeding a pre-specified recruitment rate, protocol compliance and follow-up.

RESULTS: The recruitment rate of 0.5 participants per site per month did not meet the feasibility threshold of two participants per site per month and the study was stopped early after enrolment of 24 out of the planned sample size of 40 participants. For 20/24 (83%) participants, preoperative IABC use occurred according to study assignment. Six (6)-month follow-up was available for all enrolled participants, [IABC 1 death (8%) vs. control 1 death (9%), p = 0.95].

CONCLUSION: The PINBALL Pilot recruitment rate was insufficient to demonstrate feasibility of a multicentre RCT of prophylactic IABC in high risk patients undergoing CABG surgery.

Original languageEnglish
Pages (from-to)710-718
Number of pages9
JournalHeart, Lung & Circulation
Volume29
Issue number5
Early online date3 May 2019
DOIs
Publication statusPublished - May 2020

Fingerprint

Dive into the research topics of 'Prophylactic intra-aortic balloon counterpulsation in high risk cardiac surgery: The PINBALL Pilot multicentre, registry-linked, randomised, controlled feasibility trial'. Together they form a unique fingerprint.

Cite this